D. Max Smith

2.0k total citations
32 papers, 963 citations indexed

About

D. Max Smith is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health. According to data from OpenAlex, D. Max Smith has authored 32 papers receiving a total of 963 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pharmacology, 14 papers in Pediatrics, Perinatology and Child Health and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in D. Max Smith's work include Pharmacogenetics and Drug Metabolism (20 papers), Pharmaceutical studies and practices (11 papers) and Pain Management and Opioid Use (5 papers). D. Max Smith is often cited by papers focused on Pharmacogenetics and Drug Metabolism (20 papers), Pharmaceutical studies and practices (11 papers) and Pain Management and Opioid Use (5 papers). D. Max Smith collaborates with scholars based in United States, Canada and Austria. D. Max Smith's co-authors include Larisa H. Cavallari, Julie A. Johnson, Amanda R. Elsey, Dyson T. Wake, Jean Hubble, Edison Miyawaki, Karen Busenbark, Steve Wilkinson, William C. Koller and Thorkild Norregaard and has published in prestigious journals such as Annals of Neurology, Journal of Dental Research and Clinical Pharmacology & Therapeutics.

In The Last Decade

D. Max Smith

31 papers receiving 931 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Max Smith United States	16	383	323	245	240	91	32	963
Candace Bramson United States	15	38 0.1×	46 0.1×	51 0.2×	81 0.3×	81 0.9×	36	823
Jouni Vuorinen Finland	15	43 0.1×	162 0.5×	18 0.1×	102 0.4×	53 0.6×	28	862
Pablo Zubiaur Spain	17	332 0.9×	13 0.0×	164 0.7×	26 0.1×	58 0.6×	73	877
Carol R. Reed United States	16	165 0.4×	19 0.1×	67 0.3×	93 0.4×	42 0.5×	27	1.5k
Eliane Fuseau France	17	64 0.2×	20 0.1×	249 1.0×	92 0.4×	17 0.2×	40	1.0k
Sheela Talwalker United States	12	74 0.2×	19 0.1×	28 0.1×	73 0.3×	39 0.4×	27	1.2k
Gina Mejía‐Abril Spain	15	259 0.7×	13 0.0×	128 0.5×	15 0.1×	45 0.5×	49	647
Signe T. Andersen Denmark	15	30 0.1×	269 0.8×	62 0.3×	57 0.2×	60 0.7×	29	919
Phuong‐Chi Pham United States	15	17 0.0×	37 0.1×	102 0.4×	271 1.1×	88 1.0×	26	1.1k
Beatrice Oneda Switzerland	12	251 0.7×	10 0.0×	222 0.9×	50 0.2×	36 0.4×	25	734

Countries citing papers authored by D. Max Smith

Since Specialization

Citations

This map shows the geographic impact of D. Max Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Max Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Max Smith more than expected).

Fields of papers citing papers by D. Max Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Max Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Max Smith. The network helps show where D. Max Smith may publish in the future.

Co-authorship network of co-authors of D. Max Smith

This figure shows the co-authorship network connecting the top 25 collaborators of D. Max Smith. A scholar is included among the top collaborators of D. Max Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Max Smith. D. Max Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brown, Karen E., Iris K. Minichmayr, D. Max Smith, et al.. (2025). Seasons of Growth: Reflections on the CPT Editor‐in‐Training Program. Clinical Pharmacology & Therapeutics. 118(6). 1249–1252.

Stranges, Paul M., Kathleen K. Adams, Qing Ma, et al.. (2025). Pharmacists' contributions to the management of opioid use disorder. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 8(6). 500–510. 1 indexed citations

Stevenson, James M., D. Max Smith, Sony Tuteja, & Jai N. Patel. (2025). Navigating Pharmacogenomic Testing in Practice: Who to Test and When to Test. Clinical Pharmacology & Therapeutics. 118(3). 561–566. 1 indexed citations

Smith, D. Max, Robel Beyene, Paul Kolm, et al.. (2025). A Randomized Hybrid‐Effectiveness Trial Comparing Pharmacogenomics (PGx) to Standard Care: The PGx Applied to Chronic Pain Treatment in Primary Care (PGx‐ACT) Trial. Clinical and Translational Science. 18(2). e70154–e70154. 2 indexed citations

Smith, D. Max, Michael P. Douglas, Christina L. Aquilante, et al.. (2025). Progress in Pharmacogenomics Implementation in the United States: Barrier Erosion and Remaining Challenges. Clinical Pharmacology & Therapeutics. 118(4). 778–789. 1 indexed citations

Smith, D. Max, Christina L. Aquilante, Emily J. Cicali, et al.. (2025). A Guide for Implementing DPYD Genotyping for Systemic Fluoropyrimidines into Clinical Practice. Clinical Pharmacology & Therapeutics. 117(5). 1194–1208. 2 indexed citations

Smith, D. Max, Emily J. Cicali, Christina L. Aquilante, et al.. (2024). Strategies for DPYD testing prior to fluoropyrimidine chemotherapy in the US. Supportive Care in Cancer. 32(8). 497–497. 2 indexed citations

Hertz, Daniel L., D. Max Smith, Stuart A. Scott, Jai N. Patel, & J. Kevin Hicks. (2023). Response to the FDA Decision Regarding DPYD Testing Prior to Fluoropyrimidine Chemotherapy. Clinical Pharmacology & Therapeutics. 114(4). 768–779. 22 indexed citations

Oni‐Orisan, Akinyemi, Sony Tuteja, D. Max Smith, et al.. (2023). An Introductory Tutorial on Cardiovascular Pharmacogenetics for Healthcare Providers. Clinical Pharmacology & Therapeutics. 114(2). 275–287. 6 indexed citations

10.

Lee, Andrew, et al.. (2022). Evaluation of a Longitudinal Pharmacogenomics Education on Pharmacist Knowledge in a Multicampus Healthcare System. Pharmacogenomics. 23(3). 173–182. 5 indexed citations

11.

Gammal, Roseann S., et al.. (2021). The pharmacist's responsibility to ensure appropriate use of direct‐to‐consumer genetic testing. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 4(5). 652–658. 7 indexed citations

12.

Smith, D. Max, et al.. (2021). Pharmacogenetics: A precision medicine approach to combatting the opioid epidemic. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 5(2). 239–250. 4 indexed citations

13.

Cicali, Emily J., Ku-Lang Chang, Siegfried Schmidt, et al.. (2021). Determining the potential clinical value of panel-based pharmacogenetic testing in patients with chronic pain or gastroesophageal reflux disease. The Pharmacogenomics Journal. 21(6). 657–663. 8 indexed citations

14.

Wake, Dyson T., D. Max Smith, Sadaf Kazi, & Henry M. Dunnenberger. (2021). Pharmacogenomic Clinical Decision Support: A Review, How‐to Guide, and Future Vision. Clinical Pharmacology & Therapeutics. 112(1). 44–57. 43 indexed citations

15.

Smith, D. Max, Beth N. Peshkin, Ryan P. Brown, et al.. (2020). Pharmacogenetics in Practice: Estimating the Clinical Actionability of Pharmacogenetic Testing in Perioperative and Ambulatory Settings. Clinical and Translational Science. 13(3). 618–627. 24 indexed citations

16.

Arwood, Meghan J., Eric Dietrich, Benjamin Q. Duong, et al.. (2020). Design and Early Implementation Successes and Challenges of a Pharmacogenetics Consult Clinic. Journal of Clinical Medicine. 9(7). 2274–2274. 39 indexed citations

17.

Smith, D. Max, Kristin Weitzel, Amanda R. Elsey, et al.. (2019). CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial. Genetics in Medicine. 21(8). 1842–1850. 105 indexed citations

18.

Weitzel, Kristin, D. Max Smith, Amanda R. Elsey, et al.. (2018). Implementation of Standardized Clinical Processes for TPMT Testing in a Diverse Multidisciplinary Population: Challenges and Lessons Learned. Clinical and Translational Science. 11(2). 175–181. 30 indexed citations

19.

Cavallari, Larisa H., Francesco Franchi, Fabiana Rollini, et al.. (2018). Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention. Journal of Translational Medicine. 16(1). 92–92. 45 indexed citations

20.

Koller, William C., Rajesh Pahwa, Karen Busenbark, et al.. (1997). High‐frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor. Annals of Neurology. 42(3). 292–299. 340 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact